SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-037871
Filing Date
2020-03-25
Accepted
2020-03-24 18:10:05
Documents
9
Period of Report
2020-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2011864d2_8k.htm 8-K 31605
2 EXHIBIT 4.1 tm2011864d2_ex4-1.htm EX-4.1 85637
3 EXHIBIT 4.2 tm2011864d2_ex4-2.htm EX-4.2 85098
4 EXHIBIT 10.22 tm2011864d2_ex10-22.htm EX-10.22 180438
5 EXHIBIT 10.23 tm2011864d2_ex10-23.htm EX-10.23 162923
6 EXHIBIT 99.1 tm2011864d2_ex99-1.htm EX-99.1 10997
7 EXHIBIT 99.2 tm2011864d2_ex99-2.htm EX-99.2 10778
8 GRAPHIC image_001.gif GRAPHIC 1888
9 GRAPHIC ex99-2_logo.jpg GRAPHIC 1994
  Complete submission text file 0001104659-20-037871.txt   574145
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 20739464
SIC: 2834 Pharmaceutical Preparations